BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16145001)

  • 1. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
    Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
    Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
    Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
    Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging.
    Sirol M; Aguinaldo JG; Graham PB; Weisskoff R; Lauffer R; Mizsei G; Chereshnev I; Fallon JT; Reis E; Fuster V; Toussaint JF; Fayad ZA
    Atherosclerosis; 2005 Sep; 182(1):79-85. PubMed ID: 16115477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M; Haage P; Wiethoff AJ; Günther RW; Bücker A; Tacke J; Spuentrup E
    Invest Radiol; 2009 Mar; 44(3):146-50. PubMed ID: 19151606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Mahnken AH; Günther RW; Buecker A
    Am J Respir Crit Care Med; 2005 Aug; 172(4):494-500. PubMed ID: 15937292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
    Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J
    J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.
    Botnar RM; Perez AS; Witte S; Wiethoff AJ; Laredo J; Hamilton J; Quist W; Parsons EC; Vaidya A; Kolodziej A; Barrett JA; Graham PB; Weisskoff RM; Manning WJ; Johnstone MT
    Circulation; 2004 Apr; 109(16):2023-9. PubMed ID: 15066940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E; Fausten B; Kinzel S; Wiethoff AJ; Botnar RM; Graham PB; Haller S; Katoh M; Parsons EC; Manning WJ; Busch T; Günther RW; Buecker A
    Circulation; 2005 Jul; 112(3):396-9. PubMed ID: 16009790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
    Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
    J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR molecular imaging of thrombus: development and application of a Gd-based novel contrast agent targeting to P-selectin.
    Wang XF; Jin PP; Tong Zhou ; Zhao YP; Ding QL; Wang DB; Zhao GM; Jing-Dai ; Wang HL; Ge HL
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):177-83. PubMed ID: 19141485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.